对于NACC2-NTRK2融合蛋白激活的关键领域
Wei Yang1, April N Meyer1, Zian Jiang1
1Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, California, United States of America.
PloS one
|June 27, 2024
概括
NACC2-NTRK2融合蛋白通过BTB域多元化激活NTRK2激酶活性来驱动儿科脑癌. 抑制这种BTB域可能提供一种新的癌症治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 神经营养受体氨酸激酶 (NTRK) 是细胞信号的关键调节者,它们通过突变的异常激活驱动瘤发生.
- 与NTRK相关的融合,如NACC2-NTRK2,涉及到儿科脑瘤,如皮洛细胞性星细胞瘤和质母细胞瘤.
- 了解这些融合蛋白的结构和功能领域对于开发向疗法至关重要.
研究的目的:
- 描述致癌性NACC2-NTRK2融合蛋白,确定其生物活性的关键域.
- 研究NACC2 BTB域在NTRK2激酶域的多元化和激活中的作用.
- 探索针对BTB域或融合蛋白的其他结构特征的治疗潜力.
主要方法:
- 使用局部定向突变发生来引入NACC2 BTB域 (充电口袋和单体核) 和NTRK2-衍生部分的突变.
- 与其他含有BTB的蛋白质 (例如PLZF) 的结构比较引导了突变设计.
- 进行了激酶活性测定和下游信号通路分析,以评估突变的功能影响.
主要成果:
- 在NACC2-NTRK2融合蛋白中激活NTRK2激酶域取决于NACC2 BTB域介导的多元化.
- 破坏BTB域多元化的突变显著降低了激酶活性和下游信号.
- 移除跨膜螺旋增强了融合蛋白的稳定性和活性,这表明在特定异构体的致癌性中发挥了作用.
结论:
- NACC2-NTRK2融合蛋白的致癌活性依赖于BTB域介导的多元化,这激活了NTRK2激酶.
- 针对BTB领域代表了对NACC2-NTRK2驱动癌症的有前途的治疗策略.
- 独特的NACC2-NTRK2异型,可能缺乏跨膜螺旋,可能会导致儿科质母细胞瘤的发展.
更多相关视频
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
7.5K
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
2.8K
相关概念视频
Enzyme-linked Receptors
78.0K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.0K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Assembly of Signaling Complexes
5.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.7K
